🇺🇸 FDA
Patent

US 11198694

HDAC6 inhibitors, with improved solubility and their uses

granted A61KA61K31/4375A61K31/439

Quick answer

US patent 11198694 (HDAC6 inhibitors, with improved solubility and their uses) held by Universität Regensburg expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Universität Regensburg
Grant date
Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/4375, A61K31/439, A61K45/06, A61P